MK-852

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C34H47N9O12S3
Molecular Weight	869.985
Optical Activity	UNSPECIFIED
Defined Stereocenters	6 / 6
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC2=CC=C(CN)C=C2)NC(=O)[C@H]3N(CSC3(C)C)C(=O)[C@H](CC(N)=O)NC1=O)C(O)=O

InChI

InChIKey=IHTQUFFCUYSOIH-SBTHHMAGSA-N

InChI=1S/C34H47N9O12S3/c1-16(44)38-22-13-57-58-14-23(33(54)55)42-29(50)20(10-26(47)48)39-25(46)12-37-28(49)19(8-17-4-6-18(11-35)7-5-17)40-31(52)27-34(2,3)56-15-43(27)32(53)21(9-24(36)45)41-30(22)51/h4-7,19-23,27H,8-15,35H2,1-3H3,(H2,36,45)(H,37,49)(H,38,44)(H,39,46)(H,40,52)(H,41,51)(H,42,50)(H,47,48)(H,54,55)/t19-,20-,21-,22-,23-,27+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C34H47N9O12S3
Molecular Weight	869.985
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	6 / 6
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 20:23:10 GMT 2025` Edited by `admin` on `Wed Apr 02 20:23:10 GMT 2025`
Record UNII	74L3W95S34
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MK-852

Code

English

L-367073

Preferred Name

English

L-Cysteine, N-acetyl-L-cysteinyl-L-asparaginyl-5,5-dimethyl-L-4-thiazolidinecarbonyl-4-(aminomethyl)-L-phenylalanylglycyl-L-?-aspartyl-, cyclic (1?7)-disulfide

Systematic Name

English

Code System Code Type Description

FDA UNII

74L3W95S34

Created by admin on Wed Apr 02 20:23:10 GMT 2025 , Edited by admin on Wed Apr 02 20:23:10 GMT 2025

PRIMARY

PUBCHEM

101653436

Created by admin on Wed Apr 02 20:23:10 GMT 2025 , Edited by admin on Wed Apr 02 20:23:10 GMT 2025

PRIMARY

CAS

138199-64-1

Created by admin on Wed Apr 02 20:23:10 GMT 2025 , Edited by admin on Wed Apr 02 20:23:10 GMT 2025

PRIMARY

Related Record Type Details


					6UV4YRY65X

Glycoprotein IIb/IIIa

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					74L3W95S34

MK-852

ACTIVE MOIETY

Comments:

At infusion rates of 1 ?g/kg/min for 1 hour and 0.44 ?g/kg/min for 4 hours, respectively, MK-852 extended baseline bleeding time by greater than 2.2-fold and 2.6-fold, inhibited ADP-induced platelet aggregation by 76% and 69%, and inhibited collagen-induced platelet aggregation by 65% and 67%, respectively.

Amount: